109 related articles for article (PubMed ID: 15041997)
41. p16, p14, p53, and Cyclin D1 expression and HPV analysis in small cell carcinomas of the uterine cervix by Horn et al.
Herrington CS
Int J Gynecol Pathol; 2006 Oct; 25(4):408. PubMed ID: 16990721
[No Abstract] [Full Text] [Related]
42. Usefulness of p16 for differentiating primary pulmonary squamous cell carcinoma from cervical squamous cell carcinoma metastatic to the lung.
Wang CW; Wu TI; Yu CT; Wu YC; Teng YH; Chin SY; Lai CH; Chen TC
Am J Clin Pathol; 2009 May; 131(5):715-22. PubMed ID: 19369633
[TBL] [Abstract][Full Text] [Related]
43. [Expression of DPC4/Smad4, p21wafI, and p16 in human pancreatic cancer].
Gu LJ; Chen J; Lu ZH; Li L; Zhou WX; Luo YF
Ai Zheng; 2002 Feb; 21(2):132-7. PubMed ID: 12479060
[TBL] [Abstract][Full Text] [Related]
44. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
[TBL] [Abstract][Full Text] [Related]
45. Detection of human papillomavirus DNA and expression of p16, Rb, and p53 proteins in small cell carcinomas of the uterine cervix.
Wang HL; Lu DW
Am J Surg Pathol; 2004 Jul; 28(7):901-8. PubMed ID: 15223960
[TBL] [Abstract][Full Text] [Related]
46. Intestinal-type endocervical adenocarcinoma in situ: an immunophenotypically distinct subset of AIS affecting older women.
Howitt BE; Herfs M; Brister K; Oliva E; Longtine J; Hecht JL; Nucci MR
Am J Surg Pathol; 2013 May; 37(5):625-33. PubMed ID: 23552379
[TBL] [Abstract][Full Text] [Related]
47. [Role of HPV DNA detection and p16(INK4A) protein expression in diagnosis of endocervical adenocarcinoma].
Meng ZL; Guo LN; Luo YF; Cao JL; Wan JW; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):810-3. PubMed ID: 18346352
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
Yasutake N; Yamamoto H; Kuga R; Jiromaru R; Hongo T; Katayama Y; Sonoda K; Yahata H; Kato K; Oda Y
Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
[TBL] [Abstract][Full Text] [Related]
49. [Genetic diagnosis of cervical cancer].
Sasagawa T
Nihon Rinsho; 2004 Oct; 62 Suppl 10():103-8. PubMed ID: 15535215
[No Abstract] [Full Text] [Related]
50. A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.
Kong CS; Beck AH; Longacre TA
Am J Surg Pathol; 2010 Jul; 34(7):915-26. PubMed ID: 20534993
[TBL] [Abstract][Full Text] [Related]
51. p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection.
Houghton O; Jamison J; Wilson R; Carson J; McCluggage WG
Histopathology; 2010 Sep; 57(3):342-50. PubMed ID: 20727021
[TBL] [Abstract][Full Text] [Related]
52. Lobular endocervical glandular hyperplasia is a neoplastic entity with frequent activating GNAS mutations.
Matsubara A; Sekine S; Ogawa R; Yoshida M; Kasamatsu T; Tsuda H; Kanai Y
Am J Surg Pathol; 2014 Mar; 38(3):370-6. PubMed ID: 24145653
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical Expression of the Tumor Suppressor Protein p16INK4a in Cervical Adenocarcinoma.
Eleutério J; Lima TS; Cunha MD; Cavalcante DI; Silva AM
Rev Bras Ginecol Obstet; 2017 Jan; 39(1):21-25. PubMed ID: 28245508
[No Abstract] [Full Text] [Related]
54. p16 is superior to Stathmin-1 and HSP27 in identifying cervical dysplasia.
Liou S; Nilforoushan N; Kang Y; Moatamed NA
Diagn Pathol; 2021 Sep; 16(1):85. PubMed ID: 34544445
[TBL] [Abstract][Full Text] [Related]
55. Comparing the scoring mechanisms of p16INK4a immunohistochemistry based on independent nucleic stains and independent cytoplasmic stains in distinguishing between endocervical and endometrial adenocarcinomas in a tissue microarray study.
Kok LF; Lee MY; Tyan YS; Wu TS; Cheng YW; Kung MF; Wang PH; Han CP
Arch Gynecol Obstet; 2010 Feb; 281(2):293-300. PubMed ID: 19418062
[TBL] [Abstract][Full Text] [Related]
56. A comparison of p16 INK4A immunohistochemistry, chromogenic in situ hybridization, and polymerase chain reaction genotyping for screening for human papillomavirus in basaloid squamous carcinoma.
Winters R; Evans M; Trotman W; Tang A; Elhosseiny A
Laryngoscope; 2010; 120 Suppl 4():S138. PubMed ID: 21225736
[No Abstract] [Full Text] [Related]
57. p16INK4A overexpression and HPV infection in uterine cervix adenocarcinoma.
Missaoui N; Hmissa S; Frappart L; Trabelsi A; Ben Abdelkader A; Traore C; Mokni M; Yaacoubi MT; Korbi S
Virchows Arch; 2006 May; 448(5):597-603. PubMed ID: 16496173
[TBL] [Abstract][Full Text] [Related]
58. Fascin expression in endocervical neoplasia: correlation with tumour morphology and growth pattern.
Stewart CJ; Crook M; Loi S
J Clin Pathol; 2012 Mar; 65(3):213-7. PubMed ID: 22128198
[TBL] [Abstract][Full Text] [Related]
59. The immunohistochemical assessment of HPV related adenocarcinoma: pathologic and clinical prognostic significance.
Balan R; Căruntu ID; Amălinei C
Curr Pharm Des; 2013; 19(8):1430-8. PubMed ID: 23016776
[TBL] [Abstract][Full Text] [Related]
60. Absence of high-risk human papillomavirus (HPV) detection in endocervical adenocarcinoma with gastric morphology and phenotype.
Kusanagi Y; Kojima A; Mikami Y; Kiyokawa T; Sudo T; Yamaguchi S; Nishimura R
Am J Pathol; 2010 Nov; 177(5):2169-75. PubMed ID: 20829441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
